These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1455 related items for PubMed ID: 8166929
21. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. Hrubisko M, Balázová E, Kiss F, Kovácová J, Ujházy V. Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869 [Abstract] [Full Text] [Related]
23. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice. Kido Y, Khokhar AR, Yoshida M, Thai GW, Siddik ZH. Drug Metab Dispos; 1994 Apr; 22(2):312-7. PubMed ID: 8013287 [Abstract] [Full Text] [Related]
24. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane. Anderson WK, Quagliato DA, Haugwitz RD, Narayanan VL, Wolpert-DeFilippes MK. Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155 [Abstract] [Full Text] [Related]
25. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines. Kido Y, Khokhar AR, Siddik ZH. Anticancer Drugs; 1993 Apr; 4(2):251-8. PubMed ID: 8490203 [Abstract] [Full Text] [Related]
26. Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group. Shamsuddin S, Takahashi I, Siddik ZH, Khokhar AR. J Inorg Biochem; 1996 Mar; 61(4):291-301. PubMed ID: 8867456 [Abstract] [Full Text] [Related]
27. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide. Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K. Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821 [Abstract] [Full Text] [Related]
28. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W, Chaney SG. Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361 [Abstract] [Full Text] [Related]
29. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D. Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355 [Abstract] [Full Text] [Related]
30. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR. Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318 [Abstract] [Full Text] [Related]
31. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents. Hamberger J, Liebeke M, Kaiser M, Bracht K, Olszewski U, Zeillinger R, Hamilton G, Braun D, Bednarski PJ. Anticancer Drugs; 2009 Aug 01; 20(7):559-72. PubMed ID: 19491657 [Abstract] [Full Text] [Related]
32. Drug resistance induction and cross-resistance studies with Pt-complexes. Hrubisko M, Balázová E, Ujházy V. Neoplasma; 1984 Aug 01; 31(6):649-53. PubMed ID: 6542968 [Abstract] [Full Text] [Related]
33. Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2]. Ali Khan SR, Huang S, Shamsuddin S, Inutsuka S, Whitmire KH, Siddik ZH, Khokhar AR. Bioorg Med Chem; 2000 Mar 01; 8(3):515-21. PubMed ID: 10732967 [Abstract] [Full Text] [Related]
34. Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints. Kuang J, He G, Huang Z, Khokhar AR, Siddik ZH. Clin Cancer Res; 2001 Nov 01; 7(11):3629-39. PubMed ID: 11705886 [Abstract] [Full Text] [Related]
35. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line. Mauldin SK, Gibbons G, Wyrick SD, Chaney SG. Cancer Res; 1988 Sep 15; 48(18):5136-44. PubMed ID: 3409241 [Abstract] [Full Text] [Related]
36. The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators. Kemp S, Wheate NJ, Buck DP, Nikac M, Collins JG, Aldrich-Wright JR. J Inorg Biochem; 2007 Jul 15; 101(7):1049-58. PubMed ID: 17544512 [Abstract] [Full Text] [Related]
37. Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents. Hacker MP, Khokhar AR, Krakoff IH, Brown DB, McCormack JJ. Cancer Res; 1986 Dec 15; 46(12 Pt 1):6250-4. PubMed ID: 3779645 [Abstract] [Full Text] [Related]
38. Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2]. Shamsuddin S, Santillan CC, Stark JL, Whitmire KH, Siddik ZH, Khokhar AR. J Inorg Biochem; 1998 Aug 15; 71(1-2):29-35. PubMed ID: 9755489 [Abstract] [Full Text] [Related]
39. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice. Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K. Anticancer Res; 1992 Aug 15; 12(1):49-58. PubMed ID: 1567181 [Abstract] [Full Text] [Related]